The impact of baseline liver histology on virologic response to interferon-α2b+/-ρribavirin therapy in patients with chronic hepatitis C.

被引：0
|
作者：
Fang, JS
Goodman, ZD
Albrecht, JK
Yao, R
Garaud, JJ
Lau, JN
机构：
[1] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA
[2] Armed Forces Inst Pathol, Washington, DC 20306 USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
572
引用
收藏
页码：303A / 303A
页数：1
相关论文
共 50 条
  • [31] Combination therapy with interferon-α and ribavirin in patients with dual hepatitis B and hepatitis C virus infection
    Hung, CH
    Lee, CM
    Lu, SN
    Wang, JH
    Tung, HD
    Chen, CH
    Changchien, CS
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (05) : 727 - 732
  • [32] Triple antiviral re-therapy for chronic hepatitis C with interferon-α, ribavirin and amantadine in nonresponders to interferon-α and ribavirin
    Zilly, M
    Lingenauber, C
    Desch, S
    Väth, T
    Klinker, H
    Langmann, P
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2002, 7 (04) : 149 - 154
  • [33] Response to interferon alfa 2B and ribavirin in Hispanics with hepatitis C.
    Munoz, HJ
    Arroyo, J
    Chinea, B
    Gonzalez, H
    Rodriguez, F
    Toro, D
    Torres, E
    HEPATOLOGY, 2000, 32 (04) : 348A - 348A
  • [34] Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C
    Fabris, P
    Brown, D
    Tositti, G
    Bozzola, L
    Giordani, MT
    Bevilacqua, P
    de Lalla, F
    Webster, GJM
    Dusheiko, G
    JOURNAL OF CLINICAL VIROLOGY, 2004, 29 (03) : 160 - 166
  • [35] Effect of interferon and ribavirin on progression of liver fibrosis in patients with severe chronic hepatitis C.
    Abergel, A
    Bonny, C
    Ughetto, S
    Darcha, C
    Chevalier, M
    Henquell, C
    Martineau, N
    Randl, K
    Lafeuille, H
    Aubiet-Cuvelier, B
    Bommelaer, G
    HEPATOLOGY, 2001, 34 (04) : 328A - 328A
  • [36] Soreness of mucosal membranes in patients receiving interferon-α plus ribavirin for treatment of chronic hepatitis C.
    Stauber, RE
    Trauner, M
    Fickert, P
    HEPATOLOGY, 1998, 28 (04) : 704A - 704A
  • [37] Suicidal ideation during interferon-α2b and ribavirin treatment of patients with chronic hepatitis C
    Dieperink, E
    Ho, SB
    Tetrick, L
    Thuras, P
    Dua, K
    Willenbring, ML
    GENERAL HOSPITAL PSYCHIATRY, 2004, 26 (03) : 237 - 240
  • [38] Is sustained virologic response durable in patients with chronic hepatitis C treated with interferon alfa with or without ribavirin?
    Cheinquer, N
    Cheinquer, H
    Coelho-Borges, S
    JOURNAL OF HEPATOLOGY, 2002, 36 : 103 - 103
  • [39] The effect of ribavirin and interferon-α on the differentiation of Th1 in chronic hepatitis C.
    Kobayashi, K
    Shiina, M
    Satoh, H
    Ishii, M
    HEPATOLOGY, 1999, 30 (04) : 450A - 450A
  • [40] Effect of interferon-λ4 on treatment response to peg-interferon-α-2a and ribavirin in patients with chronic hepatitis C
    Staettermayer, Albert
    Hofer, Harald
    Rutter, Karoline
    Beinhardt, Sandra
    Scherzer, Thomas-Matthias
    Steindl-Munda, Petra E.
    Ferenci, Peter
    HEPATOLOGY, 2013, 58 : 1124A - 1125A
12345